Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 6, Issue 5, 2000, Pages 401-406

  Hurley, J R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; RADIOACTIVE IODINE; THYROGLOBULIN;

BLOOD; HUMAN; MULTIMODALITY CANCER THERAPY; REVIEW; SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY;

COMBINED MODALITY THERAPY; HUMANS; IODINE RADIOISOTOPES; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY;

MLCS; MLOWN;

EID: 0034279582     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.6.5.401     Document Type: Review

References (13)